Our state-of-the-art, Clinical Laboratory Improvements Amendments (CLIA) certified clinical laboratory ensures that our patient’s have the highest quality diagnostic testing. Screening for prostate cancer using serum PSA (total and free), the evaluation of male infertility and sexual dysfunction by testing testosterone levels, and testing for both acute and chronic urinary tract infections, are all done on-site. This service ensures that our patients have the quickest turnaround time because they don’t have to wait for results to be relayed from an outside laboratory.
A.M.P. offers PCR technology
PCR technology is molecular testing for patients with recurrent or complex urinary tract infections. PCR uses state-of-the-art technology to more accurately detect most urinary pathogens.
- Provides higher sensitivity and faster turn-around times compared to standard urine culture
- Provides resistance gene information to ensure patients receive the proper treatment
All prostate biopsies and bladder biopsies that are performed in our office are processed in our Clinical Laboratory Improvements Amendments (CLIA) certified laboratory and analyzed by our board certified pathologists. Our experienced pathologists are trained to examine and diagnose cancer at every stage, and work closely with our urologists so that our patient’s can be confident that they are receiving the best possible treatment for management of their disease.
Urine cytology testing looks for abnormal cells in the urine that could be seen in conditions such as bladder cancer, or other cancers of the urinary tract system. Our American Society of Clinical Pathology (ASCP) certified cytotechnologist microscopically screens all of the cytology specimens to identify the abnormal cells. They are then reviewed and diagnosed by our pathologists, providing our patients and urologists with optimal quality assurance for the best possible care
A.M.P.’s Laboratory is accredited by The Joint Commission. Please contact the A.M.P. lab director/management at 315-558-6641 with concerns about patient safety and quality of care, or submit your concerns regarding A.M.P. lab service to The Joint Commission here.